FDA Inspection 1068543 — Glendale Adventist Medical Center

Glendale Adventist Medical Center — FEI 2074107

The FDA completed an inspection of Glendale Adventist Medical Center on Sep 18, 2018 in Glendale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 18, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Glendale, CA (United States)